Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

Nov 18 1999
The Biotechnology Industry Organization (BIO) is pleased to be invited by the Food and Drug Administration (FDA) to participate on the Food Safety Panel for...
Nov 18 1999
Thank you for inviting the Biotechnology Industry Organization (BIO) to provide a statement on the Food and Drug Administration's policy on information issues...
Nov 16 1999
WASHINGTON, D.C. (Nov. 16, 1999) -- The Biotechnology Industry Organization (BIO) fully concurs with the U.S. Food and Drug Administration's (FDA) initiative...
Nov 16 1999
WASHINGTON, D.C. -- (Carl B. Feldbaum, president of the Biotechnology Industry Organization, issued the following statement in advance of the Food and Drug...
Nov 10 1999
(Michael J. Phillips, Ph.D, Executive Director for Food & Agriculture, issued the following statement in response to Congressman Kucinich's legislation...
Nov 2 1999
Nov. 2, 1999 (Chicago) -- Genetically improved corn poses negligible harm to the Monarch butterfly population, a panel of scientists is expected to conclude at...
Oct 22 1999
WASHINGTON, D.C. (Oct. 22, 1999) -- The BiotechnologyIndustry Organization will host its second annual CEO & Investor Conference, ô2000 Reasons to Invest...
Oct 14 1999
October 14, 1999 Mr. Arthur O. Sulzberger, Jr.PublisherNew York Times229 West 43rd Street New York, NY 10036 Dear Mr. Sulzberger: On October 11, the New York...
Oct 7 1999
WASHINGTON, D.C. (October 6, 1999) -- The story ôBeyond Substantial Equivalenceö in Nature (10/7/99) is an unfounded attack on the concepts underpinning...


Biotechnology News

August 21, 2014

OVERLAND PARK, Kan.--(BUSINESS WIRE)--New York mental health, alcoholism and substance abuse treatment providers get a partner in record standardization as Netsmart's...

August 21, 2014

MORRISVILLE, N.C.--(BUSINESS WIRE)--Clinipace Worldwide, a global digital clinical research organization (dCRO), announced the company has been named to Inc. Magazine’s...

August 21, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Spero Therapeutics, LLC announces the publication of a paper in the journal PLoS Pathogens describing the first known compounds to...

August 21, 2014

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration...

August 21, 2014

DURHAM, N.C. & MANASSAS, Va.--(BUSINESS WIRE)--ATCC and bioMérieux Collaborate to Deliver Accurate Identification of Industrial Microorganisms